GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Long-Term Capital Lease Obligation

Curocell (XKRX:372320) Long-Term Capital Lease Obligation : ₩1,931.85 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Long-Term Capital Lease Obligation?

Curocell's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was ₩1,931.85 Mil.

Curocell's quarterly Long-Term Capital Lease Obligation increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩2,085.06 Mil) but then declined from Dec. 2022 (₩2,085.06 Mil) to Jun. 2023 (₩1,931.85 Mil).

Curocell's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (₩2,298.32 Mil) to Dec. 2022 (₩2,085.06 Mil) and declined from Dec. 2022 (₩2,085.06 Mil) to Dec. 2023 (₩2,020.30 Mil).


Curocell Long-Term Capital Lease Obligation Historical Data

The historical data trend for Curocell's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Long-Term Capital Lease Obligation Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
2,805.62 2,538.60 2,298.32 2,085.06 2,020.30

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Long-Term Capital Lease Obligation - 2,085.06 1,931.85 2,020.30

Curocell  (XKRX:372320) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Curocell Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Curocell's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines